FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Katja Ott

Research Profile

Disorders

Chemicals & Drugs

Procedures

Concepts & Ideas

Anatomy

Esophagogastric Junction

Co-author Network

Publications

TOP 3
Sylvie Lorenzen; Susanne Blank; Florian Lordick; Jörg Rüdiger Siewert; Katja Ott
Prediction of response and prognosis by a score including only pretherapeutic parameters in 410 neoadjuvant treated gastric cancer patients.
Lukas Bauer; Karen Becker; Alexander Hapfelmeier; Heinz Höfler; Rupert Langer; Alexander Novotny; Katja Ott; Gisela Keller
Expression profiling of stem cell-related genes in neoadjuvant-treated gastric cancer: a NOTCH2, GSK3B and β-catenin gene signature predicts survival.
Katja Ott; Christian Peschel; Tibor Schuster; Markus Schwaiger; Jörg Rüdiger Siewert; Hans-Jürgen Wester; Hinrich A Wieder; Dirk Wilhelm; Christian Meyer zum Büschenfelde; Karen Becker; Andreas K Buck; Matthias P A Ebert; Ken Herrmann; Rupert Langer; Florian Lordick; Bernd Joachim Krause
Molecular imaging of proliferation and glucose utilization: utility for monitoring response and prognosis after neoadjuvant therapy in locally advanced gastric cancer.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Katja Ott (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2012: Sylvie Lorenzen; Susanne Blank; Florian Lordick; Jörg Rüdiger Siewert; Katja Ott
Prediction of response and prognosis by a score including only pretherapeutic parameters in 410 neoadjuvant treated gastric cancer patients.
Annals of surgical oncology 2012;19(7):2119-27.
2012: Lukas Bauer; Karen Becker; Alexander Hapfelmeier; Heinz Höfler; Rupert Langer; Alexander Novotny; Katja Ott; Gisela Keller
Expression profiling of stem cell-related genes in neoadjuvant-treated gastric cancer: a NOTCH2, GSK3B and β-catenin gene signature predicts survival.
PloS one 2012;7(9):e44566.
2011: Katja Ott; Christian Peschel; Tibor Schuster; Markus Schwaiger; Jörg Rüdiger Siewert; Hans-Jürgen Wester; Hinrich A Wieder; Dirk Wilhelm; Christian Meyer zum Büschenfelde; Karen Becker; Andreas K Buck; Matthias P A Ebert; Ken Herrmann; Rupert Langer; Florian Lordick; Bernd Joachim Krause
Molecular imaging of proliferation and glucose utilization: utility for monitoring response and prognosis after neoadjuvant therapy in locally advanced gastric cancer.
Annals of surgical oncology 2011;18(12):3316-23.
2011: Christian Meyer zum Büschenfelde; Karin Becker; Matthias Ebert; Helmut Friess; Hans Geinitz; Ken Herrmann; Rupert Langer; Florian Lordick; Katja Ott; Christian Peschel; Tibor Schuster; Markus Schwaiger; Frank Zimmermann; Bernd Joachim Krause
(18)F-FDG PET-guided salvage neoadjuvant radiochemotherapy of adenocarcinoma of the esophagogastric junction: the MUNICON II trial.
Journal of nuclear medicine : official publication, Society of Nuclear Medicine 2011;52(8):1189-96.
2011: Kathrin Mutze; Alexander R Novotny; Katja Ott; Felix Schumacher; Karen Becker; Alexander Hapfelmeier; Heinz Höfler; Rupert Langer; Gisela Keller
DNA methyltransferase 1 as a predictive biomarker and potential therapeutic target for chemotherapy in gastric cancer.
European journal of cancer (Oxford, England : 1990) 2011;47(12):1817-25.
2011: Katja Ott; Florian Lordick; Susanne Blank; Markus Büchler
Gastric cancer: surgery in 2011.
Langenbeck's archives of surgery / Deutsche Gesellschaft für Chirurgie 2011;396(6):743-58.
2011: Sylvie Lorenzen; Ben Panzram; Gisela Keller; Florian Lordick; Ken Herrmann; Karin Becker; Ruppert Langer; Markus Schwaiger; Jorg Rudiger Siewert; Katja Ott
Association of the VEGF 936C>T polymorphism with FDG uptake, clinical, histopathological, and metabolic response in patients with adenocarcinomas of the esophagogastric junction.
Molecular imaging and biology : MIB : the official publication of the Academy of Molecular Imaging 2011;13(1):178-86.
2010: Christoph Schuhmacher; Stephan Gretschel; Florian Lordick; Peter Reichardt; Werner Hohenberger; Claus F Eisenberger; Cornelie Haag; Murielle E Mauer; Baktiar Hasan; John Welch; Katja Ott; Arnulf H Hoelscher; Paul M Schneider; Wolf Bechstein; Hans Wilke; Manfred P Lutz; Bernard Nordlinger; Eric Van Cutsem; Jörg R Siewert; Peter M Schlag
Neoadjuvant chemotherapy compared with surgery alone for locally advanced cancer of the stomach and cardia: European Organisation for Research and Treatment of Cancer randomized trial 40954.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2010;28(35):5210-8.
2010: Kathrin Mutze; Rupert Langer; Karen Becker; Katja Ott; Alexander R Novotny; Birgit Luber; Alexander Hapfelmeier; Martin Göttlicher; Heinz Höfler; Gisela Keller
Histone deacetylase (HDAC) 1 and 2 expression and chemotherapy in gastric cancer.
Annals of surgical oncology 2010;17(12):3336-43.
2010: Rupert Langer; Kathrin Mutze; Karen Becker; Marcus Feith; Katja Ott; Heinz Höfler; Gisela Keller
Expression of class I histone deacetylases (HDAC1 and HDAC2) in oesophageal adenocarcinomas: an immunohistochemical study.
Journal of clinical pathology 2010;63(11):994-8.
2010: Rupert Langer; Katja Ott; Marcus Feith; Florian Lordick; Katja Specht; Karen Becker; Heinz Hofler
High pretherapeutic thymidylate synthetase and MRP-1 protein levels are associated with nonresponse to neoadjuvant chemotherapy in oesophageal adenocarcinoma patients.
Journal of surgical oncology 2010;102(5):503-8.
2010: Sylvie Lorenzen; Benjamin Panzram; Robert Rosenberg; Hjalmar Nekarda; Karin Becker; Ulrich Schenk; Heinz Höfler; Jörg Rüdiger Siewert; Dirk Jäger; Katja Ott
Prognostic significance of free peritoneal tumor cells in the peritoneal cavity before and after neoadjuvant chemotherapy in patients with gastric carcinoma undergoing potentially curative resection.
Annals of surgical oncology 2010;17(10):2733-9.
2009: Gertraud Stocker; Katja Ott; Nils Henningsen; Karen Becker; Alexander Hapfelmeier; Florian Lordick; Stefan Hois; Susanne Plaschke; Heinz Höfler; Gisela Keller
CyclinD1 and interleukin-1 receptor antagonist polymorphisms are associated with prognosis in neoadjuvant-treated gastric carcinoma.
European journal of cancer (Oxford, England : 1990) 2009;45(18):3326-35.
2009: Rupert Langer; Katja Ott; Marcus Feith; Florian Lordick; Jörg Rüdiger Siewert; Karen Becker
Prognostic significance of histopathological tumor regression after neoadjuvant chemotherapy in esophageal adenocarcinomas.
Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc 2009;22(12):1555-63.
2009: Katja Ott; Franz G Bader; Florian Lordick; Marcus Feith; Holger Bartels; J Ruediger Siewert
Surgical factors influence the outcome after Ivor-Lewis esophagectomy with intrathoracic anastomosis for adenocarcinoma of the esophagogastric junction: a consecutive series of 240 patients at an experienced center.
Annals of surgical oncology 2009;16(4):1017-25.
2009: Katja Ott; Florian Lordick; Michael Molls; Holger Bartels; Edgar Biemer; Jörg Rüdiger Siewert
Limited resection and free jejunal graft interposition for squamous cell carcinoma of the cervical oesophagus.
The British journal of surgery 2009;96(3):258-66.
2008: Katja Ott; Ken Herrmann; Bernd-Joachim Krause; Florian Lordick
The Value of PET Imaging in Patients with Localized Gastroesophageal Cancer.
Gastrointestinal cancer research : GCR 2008;2(6):287-94.
2008: Sylvie Lorenzen; Björn L.D.M. Brücher; Frank B Zimmermann; Hans Geinitz; J Riera; T Schuster; N Roethling; Heinz Höfler; Katja Ott; Christian Peschel; Jörg Rüdiger Siewert; Michael Molls; Florian Lordick
Neoadjuvant continuous infusion of weekly 5-fluorouracil and escalating doses of oxaliplatin plus concurrent radiation in locally advanced oesophageal squamous cell carcinoma: results of a phase I/II trial.
British journal of cancer 2008;99(7):1020-6.
2008: Katja Ott; Ken Herrmann; Florian Lordick; Hinrich A Wieder; Wolfgang A Weber; Karen Becker; Andreas K Buck; Martin Dobritz; Ulrich Fink; Kurt Ulm; Tibor Schuster; Markus Schwaiger; Jörg Rüdiger Siewert; Bernd J Krause
Early metabolic response evaluation by fluorine-18 fluorodeoxyglucose positron emission tomography allows in vivo testing of chemosensitivity in gastric cancer: long-term results of a prospective study.
Clinical cancer research : an official journal of the American Association for Cancer Research 2008;14(7):2012-8.
2008: Jörg Theisen; K Danenberg; Katja Ott; Karen Becker; P Danenberg; Hubert J Stein; Jörg Rüdiger Siewert
Predictors of response and survival for neoadjuvant treated patients with esophageal adenocarcinoma.
Diseases of the esophagus : official journal of the International Society for Diseases of the Esophagus / I.S.D.E 2008;21(7):601-6.
2008: Hinrich A Wieder; Alexander Stahl; Florian Lordick; Katja Ott
Esophageal cancer.
Recent results in cancer research. Fortschritte der Krebsforschung. Progrès dans les recherches sur le cancer 2008;170():71-9.
2007: Ken Herrmann; Katja Ott; Andreas K Buck; Florian Lordick; Dirk Wilhelm; Michael Souvatzoglou; Karen Becker; Tibor Schuster; Hans-Jürgen Wester; Jörg R Siewert; Markus Schwaiger; Bernd J Krause
Imaging gastric cancer with PET and the radiotracers 18F-FLT and 18F-FDG: a comparative analysis.
Journal of nuclear medicine : official publication, Society of Nuclear Medicine 2007;48(12):1945-50.
2007: Hinrich A Wieder; Katja Ott; Florian Lordick; Karen Becker; Alexander Stahl; Ken Herrmann; Ulrich Fink; Jörg Rüdiger Siewert; Markus Schwaiger; Wolfgang A Weber
Prediction of tumor response by FDG-PET: comparison of the accuracy of single and sequential studies in patients with adenocarcinomas of the esophagogastric junction.
European journal of nuclear medicine and molecular imaging 2007;34(12):1925-32.
2007: Joerg R Siewert; Florian Lordick; Katja Ott; Hubert J Stein; Wolfgang A Weber; Karen Becker; Christian Peschel; Ulrich Fink; Markus Schwaiger
Induction chemotherapy in Barrett cancer: influence on surgical risk and outcome.
Annals of surgery 2007;246(4):624-8; discussion 628-31.
2007: Florian Lordick; Katja Ott; Bernd J Krause; Wolfgang A Weber; Karen Becker; Hubert J Stein; Sylvie Lorenzen; Tibor Schuster; Hinrich A Wieder; Ken Herrmann; Rainer Bredenkamp; Heinz Höfler; Ulrich Fink; Christian Peschel; Markus Schwaiger; Jörg R Siewert
PET to assess early metabolic response and to guide treatment of adenocarcinoma of the oesophagogastric junction: the MUNICON phase II trial.
The lancet oncology 2007;8(9):797-805.
2007: Hinrich A Wieder; Ken Herrmann; Katja Ott; B J Krause
[18F-FDG-PET in therapy response of esophageal cancer].
Der Radiologe 2007;47(2):110-4.
2007: Sylvie Lorenzen; Ken Herrmann; Wolfgang A Weber; Hinrich A Wieder; M Hennig; Katja Ott; Rainer Bredenkamp; Christian Peschel; Markus Schwaiger; Florian Lordick
Visualisation of metastatic oesophageal and gastric cancer and prediction of clinical response to palliative chemotherapy using 18FDG PET.
Nuklearmedizin. Nuclear medicine 2007;46(6):263-70.
2007: J Rüdiger Siewert; Katja Ott
Are squamous and adenocarcinomas of the esophagus the same disease?
Seminars in radiation oncology 2007;17(1):38-44.
2006: Katja Ott; Wolfgang A Weber; Florian Lordick; Karen Becker; Raymonde Busch; Ken Herrmann; Hinrich A Wieder; Ulrich Fink; Markus Schwaiger; Jörg Rüdiger Siewert
Metabolic imaging predicts response, survival, and recurrence in adenocarcinomas of the esophagogastric junction.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2006;24(29):4692-8.
2006: Ambros J Beer; Hinrich A Wieder; Florian Lordick; Katja Ott; Michael Fischer; Karen Becker; Jens Stollfuss; Ernst J Rummeny
Adenocarcinomas of esophagogastric junction: multi-detector row CT to evaluate early response to neoadjuvant chemotherapy.
Radiology 2006;239(2):472-80.
2005: Hinrich A Wieder; Ambros J Beer; Florian Lordick; Katja Ott; Michael Fischer; Ernst J Rummeny; Sibylle Ziegler; Jörg R Siewer; Markus Schwaiger; Wolfgang A Weber
Comparison of changes in tumor metabolic activity and tumor size during chemotherapy of adenocarcinomas of the esophagogastric junction.
Journal of nuclear medicine : official publication, Society of Nuclear Medicine 2005;46(12):2029-34.
2005: Alexander Stahl; Jens Stollfuss; Katja Ott; Hinrich A Wieder; Ulrich Fink; Markus Schwaiger; Wolfgang A Weber
FDG PET and CT in locally advanced adenocarcinomas of the distal oesophagus. Clinical relevance of a discordant PET finding.
Nuklearmedizin. Nuclear medicine 2005;44(6):249-55; quiz N55-6.
2004: Alexander Stahl; Katja Ott; Markus Schwaiger; Wolfgang A Weber
Comparison of different SUV-based methods for monitoring cytotoxic therapy with FDG PET.
European journal of nuclear medicine and molecular imaging 2004;31(11):1471-8.
2004: Wolfgang A Weber; Katja Ott
Imaging of esophageal and gastric cancer.
Seminars in oncology 2004;31(4):530-41.
2004: Alexander Stahl; Hinrich A Wieder; Hans-Jürgen Wester; Morand Piert; Florian Lordick; Katja Ott; Ernst J Rummeny; Markus Schwaiger; Wolfgang A Weber
PET/CT molecular imaging in abdominal oncology.
Abdominal imaging 2004;29(3):388-97.
2003: Katja Ott; Ulrich Fink; Karen Becker; Alexander Stahl; Hans-Joachim Dittler; Raymonde Busch; Hubert Stein; Florian Lordick; Thomas Link; Markus Schwaiger; Jörg Rüdiger Siewert; Wolfgang A Weber
Prediction of response to preoperative chemotherapy in gastric carcinoma by metabolic imaging: results of a prospective trial.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2003;21(24):4604-10.
2003: Johannes Zacherl; Andreas Sendler; Hubert J Stein; Katja Ott; Marcus Feith; Raimund Jakesz; J Rüdiger Siewert; Ulrich Fink
Current status of neoadjuvant therapy for adenocarcinoma of the distal esophagus.
World journal of surgery 2003;27(9):1067-74.
2003: Katja Ott; Wolfgang A Weber; Ulrich Fink; Hermann Helmberger; Karen Becker; Hubert J Stein; James Müller; Markus Schwaiger; Jörg Rüdiger Siewert
Fluorodeoxyglucose-positron emission tomography in adenocarcinomas of the distal esophagus and cardia.
World journal of surgery 2003;27(9):1035-9.
2003: Katja Ott; Holger Vogelsang; James Mueller; Karen Becker; Martina Müller; Ulrich Fink; Jörg Rüdiger Siewert; Heinz Höfler; Gisela Keller
Chromosomal instability rather than p53 mutation is associated with response to neoadjuvant cisplatin-based chemotherapy in gastric carcinoma.
Clinical cancer research : an official journal of the American Association for Cancer Research 2003;9(6):2307-15.
2003: Alexander Stahl; Katja Ott; Wolfgang A Weber; Karen Becker; Thomas Link; Jörg Rüdiger Siewert; Markus Schwaiger; Ulrich Fink
FDG PET imaging of locally advanced gastric carcinomas: correlation with endoscopic and histopathological findings.
European journal of nuclear medicine and molecular imaging 2003;30(2):288-95.
2003: Katja Ott; Andreas Sendler; Karen Becker; Hans-Joachim Dittler; Hermann Helmberger; Raymonde Busch; Christian Kollmannsberger; J Rüdiger Siewert; Ulrich Fink
Neoadjuvant chemotherapy with cisplatin, 5-FU, and leucovorin (PLF) in locally advanced gastric cancer: a prospective phase II study.
Gastric cancer : official journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association 2003;6(3):159-67.
2002: Hinrich A Wieder; Katja Ott; Frank Zimmermann; Hjalmar Nekarda; Jens Stollfuss; Petra Watzlowik; Jörg Rüdiger Siewert; Ulrich Fink; Karen Becker; Markus Schwaiger; Wolfgang A Weber
PET imaging with [11C]methyl- L-methionine for therapy monitoring in patients with rectal cancer.
European journal of nuclear medicine and molecular imaging 2002;29(6):789-96.
2001: Wolfgang A Weber; Katja Ott; K Becker; Hans-Joachim Dittler; Hermann Helmberger; NE Avril; G Meisetschläger; Raymonde Busch; Jörg Rüdiger Siewert; M Schwaiger; Ulrich Fink
Prediction of response to preoperative chemotherapy in adenocarcinomas of the esophagogastric junction by metabolic imaging.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2001;19(12):3058-65.
2000: T Grundei; H Vogelsang; Katja Ott; J Mueller; M Scholz; Karen Becker; Ulrich Fink; Jörg Rüdiger Siewert; Heinz Höfler; G Keller
Loss of heterozygosity and microsatellite instability as predictive markers for neoadjuvant treatment in gastric carcinoma.
Clinical cancer research : an official journal of the American Association for Cancer Research 2000;6(12):4782-8.
1998: Katja Ott; Andreas Sendler; Claus-Dieter Heidecke; Karen Becker; Hubert J Stein; Jörg Rüdiger Siewert
Bronchogenic cyst of the esophagus with high tumor marker levels--a case report and review of the literature.
Diseases of the esophagus : official journal of the International Society for Diseases of the Esophagus / I.S.D.E 1998;11(2):130-3.